HBV, HCV, HIV
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients meeting the treatment criteria for chronic hepatitis B and C issued by the Japan Society of Hepatology. Patients with confirmed diagnosis of HIV infection.
Exclusion criteria
Exclusion criteria: Contraindications in drug package inserts (those with a history of hypersensitivity to the drugs used, those taking the following drugs: rifampicin, St. John's wort, carbamazepine, phenytoin, phenobarbital, atazanavir sulfate, atorvastatin calcium hydrate)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1a. To describe percentage of patients recalled with access to treatment patients. (for diagnosed but untreated patients) 1b.Evaluate the practicality of specialist support in telemedicine for diagnosis notification, assistance in preparing application forms and certificates, treatment support system based on clinical guidelines, and patient-reported outcomes (PRO) at cooperating hospitals without specialists. 2.Performance evaluation of Large Language Model (LLM) solutions for supporting the creation of specialized application forms and certificates 3. 3)Evaluate whether 1) + 2) improved the efficiency of telemedicine. | — |
Countries
Japan
Contacts
Jichi Medical University Gastroenterology